News archive 2005

1 October 2005
INPHARMATICA Licenses ADMENSA INTERACTIVE to Mochida of Japan

1 October 2005
INNATE PHARMA Completes its Management Team with the Recruitment of Dr. Patrick Squiban as Chief Medical Officer

1 October 2005
AGENDIA BV Closes 2nd Financing Round

1 October 2005
INPHARMATICA Licenses Biopendium to Schering and Announces Druggability Collaboration

1 October 2005
BG MEDICINE and FDA to Conduct Joint Biomarker Discovery Study

1 October 2005
ABLYNX Successful in Maintaining Key Claims after NANOBODY™ Patent Challenge

1 October 2005
IDEA AG Presents Positive Phase III Data for IDEA-033, a Targeted Analgesic at the Annual Scientific Meeting of the American College of Rheumatology

1 October 2005
CROPDESIGN - Marnix Preferoen Joins CropDesign as Vice President Technology and Product Development

1 October 2005
CROPDESIGN - Multimillion EURO Deal on Developing Higher Yielding Crops

1 October 2005
BG MEDICINE Describes Role of Systems Biology in Drug Discovery and Development in Nature Reviews Drug Discovery

1 July 2005
NEURO3D - New Board Appointments

1 July 2005
AGENDIA Acquires ISO Accreditation for MammaPrint(R) Breast Cancer Risk Assessment Test

1 July 2005
ABLYNX Successful in Maintaining Key Claims after NANOBODY™ Patent Challenge

1 July 2005
ABLYNX/GILDE - Dr. Hennie Hoogenboom Appointed as Chief Scientific Officer

1 July 2005
IDEA AG announces encouraging interim results of Ph III program for pain therapeutic product IDEA-033

1 July 2005
IDEA AG - Celtic Pharma Acquires Stake in IDEA AG

1 July 2005
INPHARMATICA Announces CHEMATICA™ Collaboration with TIBOTEC PHARMACEUTICALS

1 July 2005
BG MEDICINE Announces Agreement with Boehringer Ingelheim Pharmaceuticals

1 July 2005
GILDE Sells Equity Stake in Swiss Biotech Company to Roche

1 July 2005
INPHARMATICA Launches ANNOTATION EXPRESS™

1 April 2005
PIERIS PROTEOLAB AG and Syngenta Biopharma Collaborate to Develop ANTICALINS®

1 April 2005
INPHARMATICA Launches STARLITE™ and DRUGSTORE™

1 April 2005
AGENDIA/GILDE - Professor Rene Bernards receives the NWO/Spinoza prize 2005 for his groundbreaking work in the molecular biology and diagnostics of cancer

1 April 2005
INPHARMATICA licenses ADMENSA INTERACTIVE™ to Daiichi and receives milestone payment for CHEMATICA™ services

1 April 2005
IDEA AG Starts Phase III Study with IDEA-033

1 April 2005
ABLYNX and the National Research Council Canada Sign Collaborative Deal to Develop Nanobodies for CNS Disorders

1 April 2005
INPHARMATICA Launches GPCR SARfari™: New Knowledge Base Provides Essential Information

1 April 2005
NEURO3D Reports Positive Results from Phase II Trials of Ocaperidone in Schizophrenia

1 April 2005
BG MEDICINE to Present at the SG Cowen 25th Annual Health Care Conference

1 January 2005
CHROMA THERAPEUTICS - Discovery Partners International, inc. and Chroma Therapeutics enter into collaboration for lead identification on multiple targets

1 January 2005
GLYCART Biotechnology appoints Andreas Emmenegger as Chief Financial Officer

1 January 2005
BG MEDICINE Participates As A Member Of The ''21st Century FDA Task Force'' - Focus On FDA Critical Path Initiative

1 January 2005
INPHARMATICA - SERONO Licenses ADMENSA INTERACTIVE™: A Proprietary Suite of Industry-Leading Compound Prioritization Tools

1 January 2005
INPHARMATICA Launches ADMENSA INTERACTIVE™, its Proprietary Suite of Predictive ADME Models and Compound Prioritisation Tools

1 January 2005
BEYOND GENOMICS Becomes BG MEDICINE, Appoints New President, Sharpens Focus

1 January 2005
AGENDIA Obtains Exclusive European Rigths to Arcturus Bioscience's TUO-gene Expression Profile

1 January 2005
NEURO3D Named by Tornado Insider Among Europe's Top 100 Private Tech Companies

1 January 2005
NEURO3D Initiates Phase I Trials with ND7001, a New Mechanism Antidepressant and Anxiolytic Compound

1 January 2005
INPHARMATICA Announces PHARMACARTA™ Partnership with Pfizer

1 January 2005
INPHARMATICA Announces Appointment of John Lisle as Chief Executive Officer

1 January 2005
GILDE Leads €31.5 Million Financing Round of NEURO3D

Bottles with golden caps